Revealing the epigenetic therapeutic potential of compounds derived from Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) against uterine cancer through In-silico assessments
Revealing the epigenetic therapeutic potential of compounds derived from Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) against uterine cancer through In-silico assessments. // In Silico Research in Biomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S3050787126005482?dgcid=rss_sd_all
Revealing the epigenetic therapeutic potential of compounds derived from Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) against uterine cancer through In-silico assessments. In Silico Research in Biomedicine. https://www.sciencedirect.com/science/article/pii/S3050787126005482?dgcid=rss_sd_all
“Revealing the epigenetic therapeutic potential of compounds derived from Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) against uterine cancer through In-silico assessments.” In Silico Research in Biomedicine.
@article{article48507,
title = {Revealing the epigenetic therapeutic potential of compounds derived from Citrullus colocynthis (L.) Schrad. (Cucurbitaceae) against uterine cancer through In-silico assessments},
journal = {In Silico Research in Biomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S3050787126005482?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez